If clinical trial leaders and medical professionals give people wearables when they hand out Wegovy, there’s a good chance they’ll enhance treatment success, leading to better long-term patient outcomes. Eventually, these improvements could lead to a more affordable drug and higher demand — a win-win for both the drugmaker and those looking to lose weight.